Delivery Order SPE2DB24D2011-SPE2DB25FBRWD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Quillichew ER 20 mg chewable tablets (100-count) valued at $9,871.48. The contract, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, operates under a firm fixed price structure with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Quillichew ER 40 mg chew tablets (100 count) with a ceiling value of $2,039.64. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement practices. The order is scheduled for completion by August 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Quillichew ER 30 mg chew tablets (100-count packages) valued at $2,831.31. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The order is to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Quillichew ER 30 mg chew tablets (100-count units) with a ceiling value of $3,172.60. This non-set-aside contract employs firm fixed pricing and is classified as a delivery order with an ultimate completion date of August 26, 2025. The place of performance is listed as Conshohocken, Pennsylvania, which is also the location of AmerisourceBergen's corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $1,045.00 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Quillichew ER 30 mg chewable tablets (100-count units). This competitively awarded, firm fixed-price contract requires performance at the vendor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. The contract carries no set-aside designation and represents a continuation of AmerisourceBergen's extensive role...
- The Defense Logistics Agency awarded a delivery order valued at $1,014.51 to AmerisourceBergen Drug Corp for 100 tablets of Quillichew ER 30 mg chew tablets. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of April 22, 2025. The product will be delivered to Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Quillichew ER 30 mg chew tablets in quantities of 100 units. This is a firm fixed-price delivery order with a ceiling value of $1,752.85 and an ultimate completion date of August 7, 2025. The contract was awarded on a competitive basis with no set-aside designation, and performance will be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,045.00 to AmerisourceBergen Drug Corp for the supply of Quillichew ER 30 mg chew tablets (100 count) on May 13, 2025, with an ultimate completion date of May 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a discrete transaction under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $5,852.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Quillichew ER 30 mg chew tablets in quantities of 100. The delivery order, which represents a child contract under a larger vehicle, will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 28, 2025. This award was competitively awarded with no set-aside designation. This delivery order...
- The Defense Logistics Agency awarded a $1,271.33 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Quillichew ER 30 mg chew tablets (100-count units). This non-set-aside competitive award will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB25FBRWDDelivery Order
The Defense Logistics Agency awarded a $3,029.89 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Quillichew ER 20 mg chew tablets (100 count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 17, 2025, with performance taking place at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, serving as a critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems. The company has demonstrated capability to meet federal procurement requirements through open competition, with its contract awards consistently involving delivery orders with firm fixed pricing across a diverse portfolio of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This award supports the Defense Logistics Agency's medical supply chain operations serving customers including the Defense Health Agency and U.S. Coast Guard healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 9/16/25 |